Spela Volcansek
Ljubljana, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Obese and overweight patients with type 2 diabetes mellitus are not treated optimally - is it time to reconsider clinical practice?
Journal: Expert review of clinical pharmacology
Published: July 17, 2026
Insulin delivery characteristics and glycemic control in older adults with type 1 diabetes using the Minimed™ 780G system: a real-world analysis.
Journal: Frontiers in endocrinology
Published: June 15, 2026
Letter: Metabolic Dysfunction-Associated Steatotic Liver Disease: A Silent Whisper to the Heart?
Journal: Angiology
Published: December 31, 2025
Epicardial Adipose Tissue Modulation: A New Horizon for Sodium-glucose Cotransporter 2 Inhibitors.
Journal: Current vascular pharmacology
Published: February 17, 2025
Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 13, 2025
Emerging incretin- and multi-agonist-based treatments - the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond.
Journal: Metabolism: clinical and experimental
Published: July 04, 2024
Monitoring the liver as a part of the cardio-renal-metabolic continuum - What is cooking and burning with non-invasive tests and treatment options?
Journal: Journal of diabetes and its complications
Published: June 16, 2024
Maturity-onset diabetes of the young (MODY) - in search of ideal diagnostic criteria and precise treatment.
Journal: Progress in cardiovascular diseases
Published: March 17, 2024
Recent research advances in metabolism, clinical and experimental.
Journal: Metabolism: clinical and experimental
Published: November 06, 2023
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies.
Journal: Pharmacological reviews
Published: October 06, 2023
Health-Related Quality of Life Assessment in Older Patients with Type 1 and Type 2 Diabetes.
Journal: Healthcare (Basel, Switzerland)
Published: June 07, 2023
The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials.
Journal: Medicina (Kaunas, Lithuania)
Published: April 05, 2023
Last Updated: 09/26/2026